BridgeBio Pharma, Inc.
BBIO
$68.55
$2.603.94%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 73.92% | -13.75% | 142.54% | 69.04% | 4.02% |
| Total Receivables | 78.05% | 2,853.07% | 24,276.15% | 11,546.67% | -51.05% |
| Inventory | 734.09% | -- | -- | -- | -- |
| Prepaid Expenses | 95.82% | 23.76% | 64.09% | 93.31% | 14.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 84.44% | 47.67% | -96.62% | -96.16% | 2,362.60% |
| Total Current Assets | 78.56% | 10.69% | 88.80% | 48.04% | -11.26% |
|
|
|||||
| Total Current Assets | 78.56% | 10.69% | 88.80% | 48.04% | -11.26% |
| Net Property, Plant & Equipment | 59.89% | 5.77% | -18.21% | -28.14% | -28.78% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -1.59% | 17.35% | 17.41% | 17.47% | 8.09% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.11% | -8.15% | 25.78% | -4.22% | -19.85% |
| Total Assets | 55.50% | 1.82% | 50.12% | 35.98% | 3.80% |
|
|
|||||
| Total Accounts Payable | 5.57% | 276.67% | 39.95% | 44.18% | 482.17% |
| Total Accrued Expenses | -9.18% | 92.11% | 75.28% | 44.11% | -5.69% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10,495.55% | 37.42% | 15.09% | 3.44% | 14.63% |
| Total Finance Division Other Current Liabilities | 778.56% | -55.61% | -45.11% | -29.97% | -29.08% |
| Total Other Current Liabilities | 778.56% | -55.61% | -45.11% | -29.97% | -29.08% |
| Total Current Liabilities | 436.72% | 86.51% | 55.59% | 30.88% | 7.51% |
|
|
|||||
| Total Current Liabilities | 436.72% | 86.51% | 55.59% | 30.88% | 7.51% |
| Long-Term Debt | 4.22% | 7.62% | 7.66% | 7.68% | 7.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 189.24% | -18.85% | -41.25% | -42.98% | -40.76% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 71.44% | 74.90% | 4,372.41% | 4,652.79% | 2,414.81% |
| Total Liabilities | 44.42% | 26.74% | 55.09% | 52.34% | 33.62% |
|
|
|||||
| Common Stock & APIC | 8.98% | 8.12% | 7.58% | 7.01% | 6.45% |
| Retained Earnings | -22.11% | -23.41% | -28.15% | -29.09% | -25.73% |
| Treasury Stock & Other | -25.52% | -17.55% | -17.56% | -17.55% | -17.56% |
| Total Common Equity | -38.22% | -42.15% | -57.17% | -63.58% | -57.06% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -38.22% | -42.15% | -57.17% | -63.58% | -57.06% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -2.49% | -2.56% | -10.31% | -12.84% | -23.20% |
| Total Equity | -38.46% | -42.46% | -57.81% | -64.35% | -58.04% |
|
|
|||||